P-glycoprotein in clinical cardiology

Circulation

Volumn 99, Issue 4, 1999, Pages 472-474

  Rodriguez, I ^a   Abernethy, D R ^a   Woosley, R L ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Drug resistance; Editorials; Genes; Glycoproteins; Pharmacokinetics

Indexed keywords

AMIODARONE; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; BEPRIDIL; CARDIOVASCULAR AGENT; CYCLOSPORIN A; CYTOCHROME P450 ISOENZYME; CYTOTOXIC AGENT; DACTINOMYCIN; DAUNORUBICIN; DILTIAZEM; DIPYRIDAMOLE; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; MITOMYCIN; NICARDIPINE; NIFEDIPINE; PACLITAXEL; PHENOTHIAZINE DERIVATIVE; PROPRANOLOL; QUINIDINE; RESERPINE; STEROID; TENIPOSIDE; UNINDEXED DRUG; VALSPODAR; VERAPAMIL; VINBLASTINE; VINCRISTINE;

CARDIOLOGY; DRUG BIOAVAILABILITY; DRUG DETOXIFICATION; DRUG DISPOSITION; DRUG METABOLISM; DRUG TRANSFORMATION; EDITORIAL; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

EID: 0033514259     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.4.472     Document Type: Editorial

References (20)